Life Science News

Miraculins Inc. (TSXV:MOM) will commence a program with Lovell Drugs and Pear Healthcare Solutions for the first stand-alone, Scout DS® diabetes screening kiosks placed in Lovell’s locations in Ontario. The program will begin February 15.

Miraculins Inc. (TSXV:MOM) will commence a program with Lovell Drugs and Pear Healthcare Solutions for the first stand-alone, Scout DS® diabetes screening kiosks placed in Lovell’s locations in Ontario. The program will begin February 15.

As quoted in the press release:

This proof of concept pilot is being conducted to demonstrate that a stand-alone Scout DS® diabetes screening kiosk set up inside a pharmacy location, has the ability to not only deliver a rapid, non-invasive and superior diabetes screening clinic, but can be additionally purposed to generate a meaningful financial return on investment (ROI) for the pharmacy that would not have otherwise, or readily been achievable.

Click here to read the Miraculins Inc. (TSXV:MOM) press release

See this press release on Marketwire
Click here to see the Miraculins Inc. (TSXV:MOM) profile.

MARKETS

Markets
TSX19062.91+345.79
TSXV647.33+15.54
DOW31500.68+823.32
S&P 5003911.74+116.01
NASD11607.62+375.43
ASX6528.40+19.90

COMMODITIES

Commodities
Gold1827.54+0.47
Silver21.15+0.03
Copper3.740.00
Palladium1879.51+6.50
Platinum911.26+4.32
Oil107.06+2.79
Heating Oil4.24+0.02
Natural Gas6.17-0.07

DOWNLOAD FREE REPORTS

×